Sign in
4

Changes in Ownership

AMGEN INC Filed Acc 0001127602-24-014850

EVP, R&D, & Chief Sci. Officer acquired 2,863 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bradner James E. EVP, R&D, & Chief Sci. Officer 2024-05-07 Grant or award +2,863 25,438 D
Derivatives
Bradner James E. EVP, R&D, & Chief Sci. Officer 2024-05-07 Grant or award · Nqso (Right to Buy) +18,603 $300.30 $5,586,481 18,603 D
Loading xslF345X05/form4.xml…